Acquiring Company
Tarsus Pharmaceuticals
Acquired Company
iRenix Medical
IrvineManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Tarsus Pharmaceuticals, Inc. has announced its acquisition of iRenix Medical, a clinical-stage ophthalmic biopharmaceutical company. This acquisition positions Tarsus to advance the development of IRX-101, which targets significant needs in eye care. The investment aims to improve treatment outcomes for patients facing vision loss from various retinal diseases.
Fundz sees it the moment Tarsus Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired iRenix Medical?
iRenix Medical was acquired by Tarsus Pharmaceuticals, based in Irvine. The deal was reported on July 8, 2026. Tarsus Pharmaceuticals, Inc. is a company specializing in biological products. They have shown substantial growth and have strategic initiatives in place, including the recent appointment of Dr. Tarsus Pharmaceuticals is publicly traded (TARS) and operates in Manufacturing.
When did Tarsus Pharmaceuticals acquire iRenix Medical?
Tarsus Pharmaceuticals's acquisition of iRenix Medical was reported on July 8, 2026. Tarsus Pharmaceuticals, Inc. has announced its acquisition of iRenix Medical, a clinical-stage ophthalmic biopharmaceutical company. This acquisition positions Tarsus to advance the development of IRX-101, which targets significant needs in eye care. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does iRenix Medical do?
iRenix Medical, Inc. is a privately held, clinical-stage biopharmaceutical company specializing in ocular therapeutics. The company is developing innovative solutions to reduce pain and toxicity associated with current ocular antiseptic practices. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.